Your browser doesn't support javascript.
loading
Acute Kidney Injury Biomarkers Predict an Increase in Serum Milrinone Concentration Earlier Than Serum Creatinine-Defined Acute Kidney Injury in Infants After Cardiac Surgery.
Gist, Katja M; Cooper, David S; Wrona, Julia; Faubel, Sarah; Altmann, Christopher; Gao, Zhiqian; Marino, Bradley S; Alten, Jeffrey; Hock, Kristal M; Mizuno, Tomoyuki; Vinks, Alexander A; Joy, Melanie S; Wempe, Michael F; Bennett, Michael R; Goldstein, Stuart L.
Afiliação
  • Gist KM; Division of Pediatric Cardiology, Department of Pediatrics, The Heart Institute, The University of Colorado, Children's Hospital Colorado, Aurora, Colorado.
  • Cooper DS; Department of Pediatrics, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Wrona J; Division of Pediatric Cardiology, Department of Pediatrics, The Heart Institute, The University of Colorado, Children's Hospital Colorado, Aurora, Colorado.
  • Faubel S; Department of Internal Medicine, Division of Renal Disease and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Altmann C; Department of Internal Medicine, Division of Renal Disease and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Gao Z; Heart Institute Research Core, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Marino BS; The Heart Center, Divisions of Cardiology and Critical Care Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Alten J; Department of Pediatrics, Pediatric Cardiac Critical Care Medicine, University of Alabama, Children's of Alabama, Birmingham, Alabama.
  • Hock KM; Department of Pediatrics, Pediatric Cardiac Critical Care Medicine, University of Alabama, Children's of Alabama, Birmingham, Alabama.
  • Mizuno T; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Vinks AA; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Joy MS; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Wempe MF; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Bennett MR; Department of Pediatrics, Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Goldstein SL; Department of Pediatrics, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Ther Drug Monit ; 40(2): 186-194, 2018 04.
Article em En | MEDLINE | ID: mdl-29529007
ABSTRACT

BACKGROUND:

Milrinone, an inotropic agent used ubiquitously in children after cardiac surgery, accumulates in acute kidney injury (AKI). We assessed if urinary AKI biomarkers are predictive of an increase in milrinone concentrations in infants after cardiac surgery.

METHODS:

Multicenter prospective pilot study of infants undergoing cardiac surgery. Urinary AKI biomarkers were measured in the urine at specific time intervals after cardiopulmonary bypass initiation. AKI was defined using the Kidney Disease Improving Global Outcomes serum creatinine criteria. Serum milrinone concentrations were measured at specific intervals after drug initiation, dose changes, and termination. Excessive milrinone activity was defined as a 20% increase in serum concentration between 6 and 36 hours after initiation. The temporal relationship between urinary AKI biomarker concentrations and a 20% increase in milrinone concentration was assessed.

RESULTS:

AKI occurred in 31 (33%) of infants. Milrinone clearance was lower in patients with AKI (4.2 versus 5.6 L/h/70 kg; P = 0.02). Excessive milrinone activity was associated with development of serum creatinine-defined AKI [odds ratio (OR) 3.0; 95% confidence interval (CI), 1.21-7.39; P = 0.02]. Both tissue inhibitor metalloproteinase type 2 and insulin-like growth factor-binding protein type 7 (TIMP-2*IGFBP-7) ≥0.78 at 12 hours (OR 2.72; 95% CI, 1.01-7.38; P = 0.04) and kidney injury molecule 1 (KIM-1) ≥529.57 at 24 hours (OR 2.76; 95% CI, 1.06-7.17; P = 0.04) predicted excessive milrinone activity before a diagnosis of AKI.

CONCLUSIONS:

In this pilot study, urine TIMP-2*IGFBP-7 and KIM-1 were predictive of AKI and excessive milrinone activity. Future studies that include a pharmacodynamics assessment of patient hemodynamics, excessive milrinone activity, and AKI biomarker concentrations may be warranted to integrate this concept into clinical practice.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Milrinona / Creatinina / Injúria Renal Aguda Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male / Newborn Idioma: En Revista: Ther Drug Monit Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Milrinona / Creatinina / Injúria Renal Aguda Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male / Newborn Idioma: En Revista: Ther Drug Monit Ano de publicação: 2018 Tipo de documento: Article